Leading the Way in Life Science Technologies

GEN Exclusives

More »

Best Science Apps

More »
Sep 01, 2012 (Vol. 32, No. 15)


  • Good how-to section, multiple search options
  • Nothing major
Platform: iPad/iPhone  
Cost: Free

Sure, there are plenty of proteomics resources out there, but perhaps none has the same focus on small molecule binding and proteins as “druggable” targets as Eidogen-Sertanty’s Target Informatics Platform (TIP). Combining high-resolution structures of human proteins with annotations indicating small molecule binding sites, TIP is an excellent resource for any researcher studying proteins, but especially those with an interest in drug development. Thanks to the free iProtein app, the people at Eidogen-Sertanty bring the power of TIP to your mobile devices. The app—though equipped with a fairly daunting home screen—contains a thorough how-to section to get you on your way. Users can search the protein entries of TIP by keyword, sequence accession number (if looking for sequence information) or PDB code (if searching proteins structures), or model EID (Eidogen Identifiers). In addition to searching for sequence or structure information, users can search for ligand binding sites or browse all members of a protein family.

  • Key:
  • Strong Points
  • Weak Points
  • Ratings:
  • Excellent
  • Very Good
  • Good

*The opinions expressed are solely those of the author(s) and should not be construed as reflecting the viewpoints of the publisher, Genetic Engineering & Biotechnology News, Mary Ann Liebert, Inc., the publishing house, or employees and affiliates thereof.


GEN Jobs powered by HireLifeScience.com connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
More »

Be sure to take the GEN Poll

What Does Brexit Mean for Biotech?

Do you agree with the contention that Brexit will NOT have a long-term negative impact on the British biotech industry?

More »